probucol has been researched along with Cochlear Hearing Loss in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wagle, SR | 1 |
| Ionescu, CM | 1 |
| Kovacevic, B | 1 |
| Jones, M | 1 |
| Foster, T | 1 |
| Lim, P | 1 |
| Lewkowicz, M | 1 |
| Ðanić, M | 1 |
| Mikov, M | 1 |
| Mooranian, A | 1 |
| Al-Salami, H | 1 |
1 other study available for probucol and Cochlear Hearing Loss
| Article | Year |
|---|---|
Pharmaceutical characterization of probucol bile acid-lithocholic acid nanoparticles to prevent chronic hearing related and similar cellular oxidative stress pathologies.
Topics: Antioxidants; Bile Acids and Salts; Hearing; Hearing Loss, Sensorineural; Humans; Nanoparticles; Oxi | 2023 |